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LETTER TO THE EDITOR
Eruptive Pseudoangiomatosis in a Child Undergoing Chemotherapy for
Hodgkin Lymphoma
To the Editor: Eruptive pseudoangiomatosis (EP) was original-
ly described in 1969 by Cherry et al. [1] as hemangioma-like
lesions in four children who had echovirus infections. In 1993,
the name ‘‘eruptive pseudoangiomatosis’’ was coined. The lesions
are characterized as red angioma-like eruptions, usually on the
limbs and cheeks, which appear suddenly and resolve within
2 weeks. In children, this entity has been associated with viral
etiology [2,3].
A 13-year-old Caucasian male, while undergoing the second
cycle of chemotherapy for stage IV-B Hodgkin lymphoma with
doxorubicin, bleomycin, vincristine, etoposide, cyclophospha-
mide, and prednisone per COG AHOD0932 protocol, presented
with approximately ten new-onset skin lesions. There was no
history of recent fevers, sore throat, cough, diarrhea or lymphade-
nopathy or history of affected family members. They were located
on both arms and one on the cheek, appearing as bright, angioma-
like and blanching papules surrounded by a halo (Fig. 1A,B). He
was diagnosed with EP. Differential diagnosis included bacillary
angiomatosis and spider telangiectasias. Testing for Bartonella
was negative at that time. Within 4 weeks, the lesions began to
fade, and 2 months later, they were barely visible (Fig. 1C). His
chemotherapy was completed and there has been no recurrence of
EP or Hodgkin lymphoma in the last 1 year.
EP is a benign, self-limited dermatosis, originally described in
children [4], and, more recently, in adults [5,6]. In some cases, it
has been linked to viruses and insect bites [7], and even reported
to have occurred as an outbreak in one Italian community [8]. In
both children and adults it appears as a dermatosis involving both
the limbs and the face, of small, angioma-like papules with a
surrounding halo that blanches with pressure. Dilated dermal
blood vessels with plump endothelial cells without increased
number of blood vessels and a perivascular lymphocytic inﬁltrate
are seen on histology.
In children, EP has been associated with a viral prodrome, and
in adults with immune compromise [9], and in one report, cyto-
megalovirus [10]. This case illustrates the unique circumstance of
an immunocompromised pediatric patient developing the derma-
tosis. Furthermore, the rash was not preceded by prodromal symp-
toms. This case is similar to an episode in an adult renal transplant
recipient [11] where, despite ongoing immune compromise
secondary to chemotherapy, the rash resolved. Resolution of the
dermatosis and lack of relapse re-emphasize the self-limited
nature of the condition even in immunocompromised individuals.
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Fig. 1. Eruptive pseudoangiomatosis lesions at initial presentation
(A) and (B). Lesions, nearly resolved, after 2 months (C).
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